PET/CT scans showed increased 68Ga-DOTA-IBA uptake in lymph node and meningeal metastases, indicating potential for treatment.
A 61-year-old woman diagnosed with breast cancer and bone metastases underwent a 68 Ga-labeled DOTA-ibandronic acid ( 68 Ga-DOTA-IBA) PET/CT examination to evaluate the feasibility of 177 Lu-DOTA-IBA therapy. The 68 Ga-DOTA-IBA PET/CT scan revealed multiple bone metastases throughout the body. Incidentally, the uptake of 68 Ga-DOTA-IBA was increased in the left axillary lymph node metastases and meningeal metastases.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: